[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Site Facilities::
Contact us::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Copyright Policies




Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

:: Volume 10, Issue 4 (Autumn 2022) ::
Shefaye Khatam 2022, 10(4): 71-76 Back to browse issues page
A case of Guillain-Barré syndrome following COVID-19 infection
Negar Farhoudi , Nima Javanshir * , Mohammad Negaresh
Ardabil university of medical sciences , Nimajvn95@gmail.com
Abstract:   (968 Views)
Introduction: The Covid-19 pandemic started in December 2019 and revealed various symptoms and complications, including neurological complications. Recently studies have suggested a possible link between this viral infection and Guillain-Barré syndrome (GBS). Case Description: In this report, we present a patient who after being diagnosed with Covid-19 disease, suffers from ascending peripheral neuropathy. Various diagnostic procedures support the diagnosis of GBS. Results: After treatment with plasmapheresis, an acceptable response to treatment was observed. Conclusion: Given the viral nature of COVID-19 disease and the evidence of GBS association with viral diseases, as well as the possibility of disease invasion to the respiratory system, if neurological symptoms begin in a COVID-19 patient, GBS should be included in the differential diagnosis.
Keywords: Guillain-Barre Syndrome, COVID-19, Polyradiculoneuropathy
Full-Text [PDF 793 kb]   (1370 Downloads)    
Type of Study: Case Report --- Open Access, CC-BY-NC | Subject: Neurology
1. Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes & infections. 2020; 9(1): 221-36. [DOI:10.1080/22221751.2020.1719902]
2. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. The Lancet Neurology. 2020. [DOI:10.2139/ssrn.3589350]
3. Yuki N, Hartung H-P. Guillain-Barré syndrome. New England Journal of Medicine. 2012; 366(24): 2294-304. [DOI:10.1056/NEJMra1114525]
4. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proceedings of the National Academy of Sciences. 2004; 101(31): 11404-9. [DOI:10.1073/pnas.0402391101]
5. van Balkom RH, van der Heijden HF, van Herwaarden CL, Dekhuijzen PN. Corticosteroid-induced myopathy of the respiratory muscles. Neth J Med. 1994; 45(3): 114-22.
6. Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain‐Barré syndrome. Cochrane Database of Systematic Reviews. 2016(10). [DOI:10.1002/14651858.CD001446.pub5]
7. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. The Lancet Neurology. 2008; 7(10): 939-50. [DOI:10.1016/S1474-4422(08)70215-1]
8. Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, et al. COVID‐19-associated Guillain‐Barré syndrome: The early pandemic experience. Muscle & nerve. 2020; 62(4): 485-91. [DOI:10.1002/mus.27024]

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farhoudi N, Javanshir N, Negaresh M. A case of Guillain-Barré syndrome following COVID-19 infection. Shefaye Khatam 2022; 10 (4) :71-76
URL: http://shefayekhatam.ir/article-1-2266-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 10, Issue 4 (Autumn 2022) Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.06 seconds with 45 queries by YEKTAWEB 4652